Opioid withdrawal resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 40: | Line 40: | ||
Shown below is an algorithm depicting the management of opioid withdrawal based on hospital concepts.<ref name="Huitink-2003">{{Cite journal | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi = | PMID = 12879900 }}</ref> | Shown below is an algorithm depicting the management of opioid withdrawal based on hospital concepts.<ref name="Huitink-2003">{{Cite journal | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi = | PMID = 12879900 }}</ref> | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | {{familytree | | | A01 |A01=<div style="float: left; text-align: left">'''Characterize the symptoms:''' <br>❑ Flu like illness <br>❑ Lacrimation<br> ❑ Rhinorrhea <br>❑ Sneezing<br> ❑ Yawning <br> ❑ [[Anorexia]] <br> ❑ [[Nausea]]<br> ❑ Vomiting<br> ❑ Abdominal cramps<br> ❑ [[Diarrhea]]<br> ❑ [[Myalgia]]<br> ❑ [[Arthralgia]] </div>}} | ||
{{familytree | {{familytree | | | |!| | | | | | | | }} | ||
{{familytree | {{familytree | | | B01 | | | | | | | |B01=<div style="float: left; text-align: left">'''Examine the patient:''' <br> ❑ Increase or unchanged [[blood pressure]]<br> ❑ Increase or unchanged [[heart rate]]<br> ❑ Increase or unchanged [[respiratory rate]]<br> ❑ [[Mydriasis]] <br> ❑ Piloerection <br> ❑ [[Tremor]] <br> ❑ Increased bowel sounds </div> }} | ||
{{familytree | {{familytree | | | |!| | | | | | | | | | | }} | ||
{{familytree | {{familytree | | | X01 | | | | | | | | | |X01=<div style="float: left; text-align: left">'''Consider alternative diagnosis:''' <br> ❑ Alcohol withdrawal <br> ❑ [[Sedative-hypnotic|Sedative hypnotic withdrawal]] <br> ❑ [[Cholinergic|Cholinergic poisoning]] <br> ❑ [[Sympathomimetic|Sympathomimetic intoxication]] </div>}} | ||
{{familytree | {{familytree | | | |!| | | | | | | | | | | }} | ||
{{familytree | {{familytree | | | C01 | | | | | | | | | |C01=Admit the patient }} | ||
{{familytree | {{familytree | | | |!| | | | | | | | | | | }} | ||
{{familytree | {{familytree | | | D01 | | | | | | | | | |D01=<div style="float: left; text-align: left">Start opioid agonists:<ref name="Huitink-2003">{{Cite journal | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi = | PMID = 12879900 }}</ref><br> ❑ Methadone (pure agonist) 20-35 mg daily<br> | ||
'''or'''<br> | '''or'''<br> | ||
❑ Buprenorphine (partial agonist) 4-16 mg sublingual daily <br> ❑ Taper by 3% daily over next several days | ❑ Buprenorphine (partial agonist) 4-16 mg sublingual daily <br> ❑ Taper by 3% daily over next several days | ||
Line 63: | Line 63: | ||
❑ Consult psychiatry | ❑ Consult psychiatry | ||
</div> }} | </div> }} | ||
{{familytree | {{familytree | | | |!| | | | | | | | | | | }} | ||
{{familytree | {{familytree | | | E01 | | | | | | | | | |E01=Detoxification<ref name="Huitink-2003">{{Cite journal | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi = | PMID = 12879900 }}</ref> }} | ||
{{familytree | {{familytree | |,|-|^|-|.| | | | | | | }} | ||
{{familytree | {{familytree | F01 | | F02 | | | | | |F01=<div style="float: left; text-align: left">'''Rapid detoxification:'''<ref name="O'Connor-1997">{{Cite journal | last1 = O'Connor | first1 = PG. | last2 = Carroll | first2 = KM. | last3 = Shi | first3 = JM. | last4 = Schottenfeld | first4 = RS. | last5 = Kosten | first5 = TR. | last6 = Rounsaville | first6 = BJ. | title = Three methods of opioid detoxification in a primary care setting. A randomized trial. | journal = Ann Intern Med | volume = 127 | issue = 7 | pages = 526-30 | month = Oct | year = 1997 | doi = | PMID = 9313020 }}</ref><br> For a patient receiving about 8 mg of buprenorphine or 35 mg of methadone<br>❑ Detoxify while awake or under mild sedation <br> ❑ Add [[naltrexone]]<br> | ||
:❑ Day 1: 25 mg | :❑ Day 1: 25 mg | ||
:❑ Days 2 to 15: 50 mg<br> | :❑ Days 2 to 15: 50 mg<br> | ||
❑ Add clonidine 0.1-0.2 mg four times daily, tapered on days 2 and 3<br> | ❑ Add clonidine 0.1-0.2 mg four times daily, tapered on days 2 and 3<br> | ||
❑ Antiemetic agents as needed<br>❑ Analgesics as needed</div> |F02=<div style="float: left; text-align: left">'''Ultra rapid detoxification:'''<ref name="Presslich-1989">{{Cite journal | last1 = Presslich | first1 = O. | last2 = Loimer | first2 = N. | last3 = Lenz | first3 = K. | last4 = Schmid | first4 = R. | title = Opiate detoxification under general anesthesia by large doses of naloxone. | journal = J Toxicol Clin Toxicol | volume = 27 | issue = 4-5 | pages = 263-70 | month = | year = 1989 | doi = | PMID = 2600989 }}</ref><ref name="Loimer-1991">{{Cite journal | last1 = Loimer | first1 = N. | last2 = Lenz | first2 = K. | last3 = Schmid | first3 = R. | last4 = Presslich | first4 = O. | title = Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. | journal = Am J Psychiatry | volume = 148 | issue = 7 | pages = 933-5 | month = Jul | year = 1991 | doi = | PMID = 2053636 }}</ref><br>❑ Detoxify under heavy sedation or general anesthesia<br> ❑ Induce acute withdrawal with [[naloxone]]<br> ❑ Consider intubation and mechanical ventilation if necessary<br>❑ Antiemetic agents as needed<br>❑ Analgesics as needed </div> }} | ❑ Antiemetic agents as needed<br>❑ Analgesics as needed</div> |F02=<div style="float: left; text-align: left">'''Ultra rapid detoxification:'''<ref name="Presslich-1989">{{Cite journal | last1 = Presslich | first1 = O. | last2 = Loimer | first2 = N. | last3 = Lenz | first3 = K. | last4 = Schmid | first4 = R. | title = Opiate detoxification under general anesthesia by large doses of naloxone. | journal = J Toxicol Clin Toxicol | volume = 27 | issue = 4-5 | pages = 263-70 | month = | year = 1989 | doi = | PMID = 2600989 }}</ref><ref name="Loimer-1991">{{Cite journal | last1 = Loimer | first1 = N. | last2 = Lenz | first2 = K. | last3 = Schmid | first3 = R. | last4 = Presslich | first4 = O. | title = Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. | journal = Am J Psychiatry | volume = 148 | issue = 7 | pages = 933-5 | month = Jul | year = 1991 | doi = | PMID = 2053636 }}</ref><br>❑ Detoxify under heavy sedation or general anesthesia<br> ❑ Induce acute withdrawal with [[naloxone]]<br> ❑ Consider intubation and mechanical ventilation if necessary<br>❑ Antiemetic agents as needed<br>❑ Analgesics as needed </div> }} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 16:11, 31 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]; Vendhan Ramanujam M.B.B.S [3]
Definition
Opioid withdrawal refers to the arrays of signs and symptoms following the abrupt cessation of opioids among chronic users.
Shown below is a table indicative of time to withdrawal symptoms for different opioids:[1][2]
Opioid | Peak withdrawal symptoms | Duration of symptoms |
---|---|---|
Heroin | 36-72 hours | 7-10 days |
Methadone | 72-96 hours | 14 days or more |
Buprenorphine | 36-72 hours | Intermediate between 7-14 days |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Opioid withdrawal is a life-threatening condition and must be treated as such irrespective of the causes.
Common Causes
- Discontinuation of heroin
- Discontinuation of methadone
- Rapid detoxification with naloxone or naltrexone in opioid dependent subjects
- Use of partial agonists (buprenorphine) and/or agonist-antagonists (pentazocine) in subjects not known to be opioid dependent
Management
Shown below is an algorithm depicting the management of opioid withdrawal based on hospital concepts.[3]
Characterize the symptoms: ❑ Flu like illness ❑ Lacrimation ❑ Rhinorrhea ❑ Sneezing ❑ Yawning ❑ Anorexia ❑ Nausea ❑ Vomiting ❑ Abdominal cramps ❑ Diarrhea ❑ Myalgia ❑ Arthralgia | |||||||||||||||||||||||||||||
Examine the patient: ❑ Increase or unchanged blood pressure ❑ Increase or unchanged heart rate ❑ Increase or unchanged respiratory rate ❑ Mydriasis ❑ Piloerection ❑ Tremor ❑ Increased bowel sounds | |||||||||||||||||||||||||||||
Consider alternative diagnosis: ❑ Alcohol withdrawal ❑ Sedative hypnotic withdrawal ❑ Cholinergic poisoning ❑ Sympathomimetic intoxication | |||||||||||||||||||||||||||||
Admit the patient | |||||||||||||||||||||||||||||
Start opioid agonists:[3] ❑ Methadone (pure agonist) 20-35 mg daily or Add nonopioid drugs: ❑ General symptomatic management ❑ Consult psychiatry | |||||||||||||||||||||||||||||
Detoxification[3] | |||||||||||||||||||||||||||||
Rapid detoxification:[7] For a patient receiving about 8 mg of buprenorphine or 35 mg of methadone ❑ Detoxify while awake or under mild sedation ❑ Add naltrexone
❑ Add clonidine 0.1-0.2 mg four times daily, tapered on days 2 and 3 ❑ Analgesics as needed | |||||||||||||||||||||||||||||
BID: Twice daily
Do's
- Restrict methadone and other opioid agonists to inpatient settings or licensed programs.
- Administer chlordiazepoxide, a longer-acting benzodiazepine to augument clonidine in patients with insomnia or muscle cramps.[5]
- Detoxification should be undertaken only under clinicians with special training, equipment, or both.
- Start buprenorphine at least two days before starting naltrexone during detoxification.
Dont's
- Do not abruptly stop drugs that are being used to treat withdrawal.
References
- ↑ Jasinski, DR.; Pevnick, JS.; Griffith, JD. (1978). "Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction". Arch Gen Psychiatry. 35 (4): 501–16. PMID 215096. Unknown parameter
|month=
ignored (help) - ↑ Opiods: detoxification. In: Galanter M, Kleber HD, eds. The American Psychiatric Press textbook of substance abuse treatment. 2nd ed. Washington, D.C.: American Psychiatric Press, 1999:251-69.>
- ↑ 3.0 3.1 3.2 Huitink, J.; Buitelaar, D. (2003). "Management of drug and alcohol withdrawal". N Engl J Med. 349 (4): 405–7, author reply 405-7. PMID 12879900. Unknown parameter
|month=
ignored (help) - ↑ Senay, EC.; Dorus, W.; Goldberg, F.; Thornton, W. (1977). "Withdrawal from methadone maintenance. Rate of withdrawal and expectation". Arch Gen Psychiatry. 34 (3): 361–7. PMID 843188. Unknown parameter
|month=
ignored (help) - ↑ 5.0 5.1 O'Connor, PG.; Waugh, ME.; Carroll, KM.; Rounsaville, BJ.; Diagkogiannis, IA.; Schottenfeld, RS. (1995). "Primary care-based ambulatory opioid detoxification: the results of a clinical trial". J Gen Intern Med. 10 (5): 255–60. PMID 7616334. Unknown parameter
|month=
ignored (help) - ↑ Strang, J.; Bearn, J.; Gossop, M. (1999). "Lofexidine for opiate detoxification: review of recent randomised and open controlled trials". Am J Addict. 8 (4): 337–48. PMID 10598217.
- ↑ O'Connor, PG.; Carroll, KM.; Shi, JM.; Schottenfeld, RS.; Kosten, TR.; Rounsaville, BJ. (1997). "Three methods of opioid detoxification in a primary care setting. A randomized trial". Ann Intern Med. 127 (7): 526–30. PMID 9313020. Unknown parameter
|month=
ignored (help) - ↑ Presslich, O.; Loimer, N.; Lenz, K.; Schmid, R. (1989). "Opiate detoxification under general anesthesia by large doses of naloxone". J Toxicol Clin Toxicol. 27 (4–5): 263–70. PMID 2600989.
- ↑ Loimer, N.; Lenz, K.; Schmid, R.; Presslich, O. (1991). "Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates". Am J Psychiatry. 148 (7): 933–5. PMID 2053636. Unknown parameter
|month=
ignored (help)